{
  "DOI": "10.1007/s10689-015-9825-9",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9825-9",
  "alternative-id": [
    "9825"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Basu",
      "given": "N. N.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ingham",
      "given": "S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hodson",
      "given": "J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lalloo",
      "given": "F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bulman",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Evans",
      "given": "D. G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        8,
        3
      ]
    ],
    "date-time": "2015-08-03T08:11:18Z",
    "timestamp": 1438589478000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:16Z",
    "timestamp": 1559252776000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        11
      ]
    ],
    "date-time": "2024-04-11T15:48:21Z",
    "timestamp": 1712850501303
  },
  "is-referenced-by-count": 42,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2015,
        8,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2015,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            8,
            4
          ]
        ],
        "date-time": "2015-08-04T00:00:00Z",
        "timestamp": 1438646400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9825-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9825-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9825-9",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "531-538",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        8,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        8,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "journal-title": "Am J Hum Genet",
      "key": "9825_CR1",
      "unstructured": "Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families, The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1186/1471-2407-8-155",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "journal-title": "BMC Cancer",
      "key": "9825_CR2",
      "unstructured": "Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risk of breast/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8:155. doi: 10.1186/1471-2407-8-155",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1399-0004.2012.01859.x",
      "author": "F Lalloo",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "journal-title": "Clin Genet",
      "key": "9825_CR3",
      "unstructured": "Lalloo F, Evans DG (2012) Familial breast cancer. Clin Genet 82:105–114",
      "volume": "82",
      "year": "2012"
    },
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "journal-title": "J Natl Cancer Inst",
      "key": "9825_CR4",
      "unstructured": "Thompson D, Easton DF (2002) Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.bjc.6605606",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "1091",
      "journal-title": "Br J Cancer",
      "key": "9825_CR5",
      "unstructured": "Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F et al (2010) Long term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status. Br J Cancer 102:1091–1098",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03258-X",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1876",
      "journal-title": "Lancet",
      "key": "9825_CR6",
      "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876–1881",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1155/2015/901046",
      "doi-asserted-by": "crossref",
      "key": "9825_CR7",
      "unstructured": "Basu NN, Barr L, Ross GL, Evans DG (2015) Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies. Int J Surg Oncol 2015:901046. doi: 10.1155/2015/901046 . Epub 2015 Jan 27. Review"
    },
    {
      "DOI": "10.1054/bjoc.2000.1239",
      "author": "LC Verhoog",
      "doi-asserted-by": "crossref",
      "first-page": "384",
      "journal-title": "Br J Cancer",
      "key": "9825_CR8",
      "unstructured": "Verhoog LC, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG (2000) Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer 83:384–386",
      "volume": "83",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2004.04.033",
      "author": "K Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "2328",
      "journal-title": "J Clin Oncol",
      "key": "9825_CR9",
      "unstructured": "Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22:2328–2335",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ijc.21536",
      "author": "J Gronwald",
      "doi-asserted-by": "crossref",
      "first-page": "2281",
      "journal-title": "Int J Cancer",
      "key": "9825_CR10",
      "unstructured": "Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M et al (2006) Hereditary Breast Cancer Clinical Study Group. Tamoxifen and contralateral breast cancer in BRCA1 BRCA2 carriers: an update. Int J Cancer 118:2281–2284",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-014-2890-1",
      "author": "A Valachis",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9825_CR11",
      "unstructured": "Valachis A, Nearchou AD, Lind P (2014) Surgical management of breast cancer in BRCA mutation carriers: a systematic review and meta-analysis. Breast Cancer Res Treat 144(3):443–455. doi: 10.1007/s10549-014-2890-1",
      "volume": "144",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/djv033",
      "doi-asserted-by": "crossref",
      "key": "9825_CR12",
      "unstructured": "Heemskerk-Gerritsen BA, Sevnaeve C, van Asperen CJ, Ausems MG, Collee JM et al (2015) Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Nat Cancer Inst 107(5):djv033. doi: 10.1093/jnci/djv033"
    },
    {
      "DOI": "10.1038/nature05887",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "1087",
      "journal-title": "Nature",
      "key": "9825_CR13",
      "unstructured": "Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2447:1087–1093",
      "volume": "2447",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-1907",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "9742",
      "journal-title": "Cancer Res",
      "key": "9825_CR14",
      "unstructured": "Antoniou AC, Beesley J, McGuffog L, Sinilnikova DM, Healey S, Neuhausen SL et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70:9742–9754",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.586",
      "author": "C Turnbull",
      "doi-asserted-by": "crossref",
      "first-page": "504",
      "journal-title": "Nat Genet",
      "key": "9825_CR15",
      "unstructured": "Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M et al (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42:504–507",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pgen.1003212",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "e1003212",
      "issue": "3",
      "journal-title": "PLoS Genet",
      "key": "9825_CR16",
      "unstructured": "Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB et al (2013) Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 9(3):e1003212. doi: 10.1371/journal.pgen.1003212",
      "volume": "9",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pgen.1003173",
      "author": "MM Gaudet",
      "doi-asserted-by": "crossref",
      "first-page": "e1003173",
      "issue": "3",
      "journal-title": "PLoS Genet",
      "key": "9825_CR17",
      "unstructured": "Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchoff T, McGuffog L et al (2013) Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 9(3):e1003173. doi: 10.1371/journal.pgen.1003173",
      "volume": "9",
      "year": "2013"
    },
    {
      "author": "SL Ingham",
      "journal-title": "Clin Genet",
      "key": "9825_CR18",
      "unstructured": "Ingham SL, Warwick J, Byers H, Lalloo F, Newman WG, Evans DGR (2012) Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large genetic centre in the UK. Clin Genet. doi: 10.1111/cge.12035",
      "year": "2012"
    },
    {
      "DOI": "10.1136/bmj.g226",
      "author": "K Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "g226",
      "journal-title": "BMJ",
      "key": "9825_CR19",
      "unstructured": "Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N et al (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: a retrospective analysis. BMJ 348:g226. doi: 10.1136/bmj.g226",
      "volume": "348",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-013-2583-1",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9825_CR20",
      "unstructured": "Evans DG, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, Howell A (2013) Contralateral mastectomy improves survival in women with BRCA1/2- associated breast cancer. Breast Cancer Res Treat 140(1):135–142",
      "volume": "140",
      "year": "2013"
    },
    {
      "author": "BA Heemskerk-Gerritsen",
      "first-page": "665",
      "issue": "3",
      "journal-title": "Int J Cancer",
      "key": "9825_CR21",
      "unstructured": "Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collee JM, Jansen L et al (2015) Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer 136(3):665–677",
      "volume": "136",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s13058-014-0442-6",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "442",
      "issue": "5",
      "journal-title": "Breast Cancer Res",
      "key": "9825_CR22",
      "unstructured": "Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C et al (2014) The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res 16(5):442. doi: 10.1186/s13058-014-0442-6",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2008.19.9430",
      "author": "MK Graeser",
      "doi-asserted-by": "crossref",
      "first-page": "5887",
      "journal-title": "J Clin Oncol",
      "key": "9825_CR23",
      "unstructured": "Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27:5887–5892",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "SK Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "journal-title": "JAMA",
      "key": "9825_CR24",
      "unstructured": "Domchek SK, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2005.02.7888",
      "author": "LJ Pierce",
      "doi-asserted-by": "crossref",
      "first-page": "2437",
      "issue": "16",
      "journal-title": "J Clin Oncol",
      "key": "9825_CR25",
      "unstructured": "Pierce LJ, Levin AM, Rebbeck TR et al (2006) Ten year multi-institutional results of breast conserving surgery and radiotherapy in BRCA1/2 associated stage I/II breast cancer. J Clin Oncol 24(16):2437–2443",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr3369",
      "author": "K Rhiem",
      "doi-asserted-by": "crossref",
      "first-page": "R156",
      "journal-title": "Breast Cancer Res",
      "key": "9825_CR26",
      "unstructured": "Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M et al (2012) The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res 14:R156",
      "volume": "14",
      "year": "2012"
    },
    {
      "key": "9825_CR27",
      "unstructured": "Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE (2013) Review of risk factors for the development of contralateral breast cancer. Am J Surg S0002-9610(13): 00415–7 (Epub ahead of print)"
    },
    {
      "DOI": "10.1200/JCO.2012.47.8313",
      "author": "KA Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "3091",
      "issue": "25",
      "journal-title": "J Clin Oncol",
      "key": "9825_CR28",
      "unstructured": "Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC et al (2013) Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 31(25):3091–3099",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1186/bcr1670",
      "author": "G Chenevix-Trench",
      "doi-asserted-by": "crossref",
      "first-page": "104",
      "journal-title": "Breast Cancer Res",
      "key": "9825_CR29",
      "unstructured": "Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104",
      "volume": "9",
      "year": "2007"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9825-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}